EGFR and cholangiocarcinoma: EGFR overexpression was assessed in different studies with heterogeneous results ranging from 10% to 81% positivity for intrahepatic CC [213,214,215,216,217,218] and approximately 20% for extrahepatic CC [218,219,220].